PROSTATE CANCER RESEARCH — grant history
Latest income
£5.2m
Grants listed (FY2024)
18
Listed grants total
£1.6m
Accounts grants total
£1.6m
listed grants reconcile with the accounts totalextracted from its FY2024 accounts
Application guidance — from the funder’s own website
- How to apply: The website lists a link to 'Apply to our Seed Grants' under the 'PCR Funding for Scientists' section, but does not provide specific instructions, forms, or eligibility criteria on this page.
What this funder supports
Causes funded
- Education/training
- The Advancement Of Health Or Saving Of Lives
- Arts/culture/heritage/science
Where grantees operate
- Throughout England And Wales
- Cardiff
- Northern Ireland
- Scotland
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Cambridge | FY2024 | £199k | PTEN and TSGs |
| Cardiff University | FY2024 | £162k | Bone mets/Wnt |
| University of East Anglia | FY2024 | £128k | AI/Mathematical Classification |
| University of East Anglia | FY2024 | £122k | Disparities/PCR test |
| Imperial College London | FY2024 | £121k | Obesity-driven PC |
| University of Oxford | FY2024 | £105k | 177Lu-PSMA |
| University of Sunderland | FY2024 | £105k | Disparities/Barriers to early diagnosis |
| University of Aberdeen | FY2024 | £98k | SoloMERS |
| Newcastle University | FY2024 | £93k | Bone mets/glycans |
| Newcastle University | FY2024 | £82k | AR-V Splicing |
| University of Cambridge | FY2024 | £82k | ProCASP |
| CRUK Beatson Institute | FY2024 | £59k | MCL-1 |
| Newcastle University | FY2024 | £50k | Bone mets/glycans |
| University of Essex | FY2024 | £47k | Disparities/AR risk |
| Other Grants costs | FY2024 | £46k | |
| Kings College London | FY2024 | £41k | PlexinB1 |
| UCL | FY2024 | £38k | STAMPEDE |
| UCL | FY2024 | £35k | Disparities/treatment patterns |
| Cambridge University | FY2023 | £148k | Wnt Signalling |
| Aberdeen University | FY2023 | £144k | Bone mets/Targeting Signalling |
| King's College London | FY2023 | £137k | Immunotherapy |
| University of East Anglia | FY2023 | £134k | Machine learning models |
| Cardiff University | FY2023 | £134k | PlexinB1 |
| University of Sunderland | FY2023 | £122k | Al/Mathematical Classification |
| Oxford University | FY2023 | £98k | ProCASP |
| Cancer Research UK | FY2023 | £86k | AR-V Splicing |
| Other Grants costs | FY2023 | £70k | Targeting MCL-1 |
| UCL | FY2023 | £52k | 177Lu-PSMA |
| Newcastle University | FY2023 | £51k | Solo MERS |
| Imperial College London | FY2023 | £49k | Glycan drugs targeting bone metastasis |
| Francis Crick institute | FY2023 | £48k | PTEN and TSGs |
| Other Grants costs | FY2023 | £34k | Disparities/AR risk |
| University of Essex | FY2023 | £31k | STAMPEDE |
| Other Grants costs | FY2023 | £22k | Disparities/Barriers to early diagnosis |
| Other Grants costs | FY2023 | £12k | Obesity and Prostate Cancer |